F Swan - Concepedia

Author

F Swan

The University of Texas MD Anderson Cancer Center

Also Known As

F SWAN, F Swan, F. Swan, Forrest Swan

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Lymphoma Research Foundation

About

F Swan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.2K
2	Immunology	6	6	406
3	Health Sciences	3	3	107
4	Cell Biology	1	1	11
5	Obstetrics	1	1	131

F Swan

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP) WS Velasquez, Fernando Cabanillas, P. Salvador, Blood	1988	578
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. William S. Velasquez, Peter McLaughlin, Fredrick B. Hagemeister, Journal of Clinical Oncology	1994	427
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma. Peter McLaughlin, Fredrick B. Hagemeister, Jorge Romaguera, Journal of Clinical Oncology	1996	263
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma. J R Redman, Fernando Cabanillas, W S Velasquez, Journal of Clinical Oncology	1992	201
A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. F Swan, William S. Velasquez, S. C. Tucker, Journal of Clinical Oncology Ann ArborLymphoid NeoplasiaMedicineLactate DehydrogenaseSurgical Pathology	1989	159
Radiotherapy during pregnancy for clinical stages IA–IIA Hodgkin's disease Shiao Y. Woo, Lillian M. Fuller, Jackson Cundiff, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyMedicineGynecologyMaternal Health	1992	131
Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival data WS Velasquez, S Jagannath, S.L. Tucker, Blood	1989	113
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP. Maritza Rodríguez, Fernando Cabanillas, William S. Velasquez, Journal of Clinical Oncology	1995	105
Prognostic Value of Serum β-2 Microglobulin in Low-Grade Lymphoma Patrick P. Litam, F Swan, Fernando Cabanillas, Annals of Internal Medicine	1991	102
ASHAP: A Regimen for Cytoreduction of Refractory or Recurrent Hodgkin’s Disease José A. Rodríguez, Maria Alma Rodriguez, Luis Fayad, Blood	1999	94

Page 1